13-oxo-9,11-octadecadienoic acid has been researched along with quercetin 3-o-methyl ether in 1 studies
| Studies (13-oxo-9,11-octadecadienoic acid) | Trials (13-oxo-9,11-octadecadienoic acid) | Recent Studies (post-2010) (13-oxo-9,11-octadecadienoic acid) | Studies (quercetin 3-o-methyl ether) | Trials (quercetin 3-o-methyl ether) | Recent Studies (post-2010) (quercetin 3-o-methyl ether) |
|---|---|---|---|---|---|
| 5 | 0 | 5 | 47 | 0 | 23 |
| Protein | Taxonomy | 13-oxo-9,11-octadecadienoic acid (IC50) | quercetin 3-o-methyl ether (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 1.904 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 1.904 | |
| rac GTPase-activating protein 1 isoform a | Homo sapiens (human) | 30.34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kishore, N; Kumar, P; Shanker, K; Verma, AK | 1 |
1 review(s) available for 13-oxo-9,11-octadecadienoic acid and quercetin 3-o-methyl ether
| Article | Year |
|---|---|
Human disorders associated with inflammation and the evolving role of natural products to overcome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Biological Products; Cardiovascular Diseases; Humans; Inflammation; Neoplasms; Skin Diseases | 2019 |